The fibrinogen/CRP ratio as a new parameter for the diagnosis of disseminated intravascular coagulation in patients with HELLP syndrome and as a predictive factor for neonatal outcome

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 2, 2013, Pages 118.e1-118.e7

  Windsperger, Karin ^a   Lehner, Rainer ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

disseminated intravascular coagulation; fibrinogen CRP ratio; HELLP syndrome

Indexed keywords

ANTITHROMBIN; C REACTIVE PROTEIN; FIBRINOGEN; LIVER ENZYME; PROTHROMBIN; THROMBIN;

ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; THROMBIN TIME;

EID: 84872849730     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.11.025     Document Type: Article

References (16)

1. L. Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy Am J Obstet Gynecol 142 1982 159 167
2. D. Mihu, N. Costin, C.M. Mihu, A. Seicean, R. Ciortea HELLP syndrome - a multisystemic disorder J Gastrointestin Liver Dis 16 2007 419 424
3. J.G. Aarnoudse, H.J. Houthoff, J. Weits, E. Vellenga, H.J. Huisjes A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: a clinical and histopathological study Br J Obstet Gynaecol 93 1986 145 155
4. J.F. Abbade, J.C. Peraçoli, R.A. Costa, M. Calderon Ide, V.T. Borges, M.V. Rudge Partial HELLP syndrome: maternal and perinatal outcome Sao Paulo Med J 120 2002 180 184
5. P.A. Van Dam, M. Renier, M. Backelandt, P. Butyaert, F. Uyttenbroeck Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia Obstet Gynecol 73 1989 97 102
6. M.E. McBrien, D.L. Coppel Intensive care management of the HELLP syndrome Ulster Med J 64 1995 173 177
7. R.L. Bick Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response Semin Thromb Hemost 22 1996 69 88
8. K. Bakhtiari, J.C. Meijers, E. de Jonge, M. Levi Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2004 2416 2421
9. F.B. Taylor Jr, C.H. Toh, W.K. Hoots, H. Wada, M. Levi Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
10. A. Karowicz-Bilinska, U. Kowalska-Koprek, J. Suzin Evaluation of some coagulation parameters in pregnant women with arterial hypertension Ginekol Pol 74 2003 55 60
11. I. Alacacioglu, M. Özcan, M. Polat Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant women Thromb Res 114 2004 155 159
12. B. Haddad, R. Barton, J. Livingston, M. Sibai Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome Am J Obstet Gynecol 183 2000 444 448
13. O. Kor-anantakul, A. Lekhakula Overt disseminated intravascular coagulation in obstetric patients J Med Assoc Thai 90 2007 857 864
14. H. Kim, D. Lee, S. Kang, J. Kim Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation Acta Haematologica 117 2007 34 39
15. B.M. Sibai The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 162 1990 311 316
16. J. Cohen A power primer Quant Meth Psychol 112 1992 155 159